Cost-Benefit Analysis of Human Papillomavirus Vaccine in Iran.
Sargazi N, Takian A, Daroudi R, Nahvijou A, Yaseri M, Ghanbari Motlagh A, Zendehdel K.
Sargazi N, et al.
J Prev (2022). 2022 Dec;43(6):841-857. doi: 10.1007/s10935-022-00697-w. Epub 2022 Aug 2.
J Prev (2022). 2022.
PMID: 35916995
We performed a CBA from a societal perspective. We used two approaches of the vaccine's economic benefits: willingness to pay by discrete choice experiment and cost of illness. ...The cost of two doses of bivalent and quadrivalent vaccines were US $29 and the US $151, resp …
We performed a CBA from a societal perspective. We used two approaches of the vaccine's economic benefits: willingness to pay by disc …